Abstract
Glioblastomas are the most frequent and devastating brain tumors in adults. Molecular and cytogenetic studies of glioblastomas have revealed a wide variety of deregulated genes that are associated with cell cycles, DNA repair, apoptosis, cell migration, invasion, and angiogenesis with little translational success. Understanding the molecular mechanisms of these deregulated genes can provide a rationale for targeting specific pathways of repair, signaling, and angiogenesis. Taxol, one of the most potent anti-neoplastic drugs, strongly binds to the N-terminal region of β-tubulin to prevent tumor cell division and induce cell death. The effects of taxol may vary depending on cell type and drug concentration. At lower concentrations ranging from 10 to 100 nM, taxol induces phosphorylation of Bcl-2, which in turn triggers mitochondrial release of cytochrome c, cleavage of pro-caspases and poly(ADP-ribose) polymerase (PARP), leading to apoptotic death. Phosphorylation of Bcl-2 also inhibits the ability of Bcl-2 to increase intracellular free [Ca2+], which triggers calpain-mediated apoptosis. At higher concentrations, taxol induces cell death due to stabilization of microtubules and mitochondrial collapse, leading to cell cycle arrest at G2/M phase. Disruption of the mitotic spindle activates a number of signaling pathways, with consequences that may protect the cell. The cells arrested in mitosis exhibit no signal for apoptosis but have an increased expression of survivin, an inhibitor of apoptosis. A thorough understanding of the molecular signaling events associated with taxol-mediated cell cycle arrest is essential, particularly in regard to its potential in combination therapy, where multiple therapeutic agents are used to enhance the efficacy of treatment in controlling cancer cells. In this chapter, we present an overview of the latest research on the molecular signaling mechanisms of taxol, events leading to apoptosis, potential of taxol in combination chemotherapy, and emerging gene therapy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Barnholtz-Sloan JS, Sloan AE, Schwartz AG (2003) Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 98:603–609
Baum SG, Wittner M, Nadler JP, Horwitz SB, Dennis JE, Schiff PB, Tanowitz HB (1981) Taxol, a microtubule stabilizing agent, blocks the replication of Trypanosoma cruzi. Proc Natl Acad Sci USA 78:4571–4575
Bellavance MA, Blanchette M, Fortin D (2008) Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J 10:166–177
Broker LE, Huisman C, Span SW, Rodriguez JA, Kruyt FAE, Giaccone G (2004) Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64:27–30
Castro MG, Cowen R, Williamson IK, David A, Jimenez-Dalmaroni MJ, Yuan X, Bigliari A, Williams JC, Hu J, Lowenstein PR (2003) Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther 98:71–108
Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D (2005) Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 104:2168–2173
Connelly JM, Malkin MG (2007) Environmental risk factors for brain tumors. Curr Neurol Neurosci Rep 7:208–214
Day TW, Najafi F, Wu CH, Safa AR (2006) Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis. Biochem Pharmacol 71:1551–1561
Díaz JF, Andreu JM (1993) Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 32:2747–2755
Díaz JF, Pantos E, Bordas J, Andreu JM (1994) Solution structure of GDP-tubulin double rings to 3 nm resolution and comparison with microtubules. J Mol Biol 238:214–225
Díaz JF, Strobe R, Engelborghs Y, Souto AA, Andreu JM (2000) Molecular recognition of taxol by microtubules: Kinetics and thermodynamics of binding of fluorescent taxol derivatives to an exposed site. J Biol Chem 275:26265–26276
Ding AH, Porteu F, Sanchez E, Nathan CF (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248:370–372
Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24:1266–1272
Dziadyk JM, Sui M, Zhu X, Fan W (2004) Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res 24:27–36
Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O-6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59:793–797
Fan W (1999) Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol 57:1215–1221
Figueroa-Masot XA, Hetman M, Higgins MJ, Kokot N, Xia Z (2001) Taxol induces apoptosis in cortical neurons by a mechanism independent of Bcl-2 phosphorylation. J Neurosci 21:4657–4667
Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25:867–890
Ganesh T, Yang C, Norris A, Glass T, Bane S, Ravindra R et al (2007) Evaluation of the tubulin-bound paclitaxel conformation: synthesis, biology, and SAR studies of C-4 to C-3′ bridged paclitaxel analogues. J Med Chem 50:713–725
George J, Gondi CS, Dinh DH, Gujrati M, Rao JS (2007) Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis. Clin Cancer Res 13:3507–3517
George J, Banik NL, Ray SK (2009) Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells, and inhibits invasion, angiogenesis and tumor growth. J Cell Mol Med (in press), DOI: 10.1111/j.1582-4934-2008.00539.x
George J, Banik NL, Ray SK (2009) Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res 34:66–78
Gibson JD, Khanal BP, Zubarev ER (2007) Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 129:11653–11661
Holton RA, Kim HB, Somoza C, Liang F, Biediger RJ, Boatman PD et al (1994a) First total synthesis of taxol. 2. Completion of the C and D rings. J Am Chem Soc 116:1599–1600
Holton RA, Somoza C, Kim HB, Liang F, Biediger RJ, Boatman PD et al (1994b) First total synthesis of taxol. 1. Functionalization of the B ring. J Am Chem Soc 116:1597–1598
Hribaschek A, Meyer F, Schneider-Stock R, Pross M, Ridwelski K, Lippert H (2007) Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis. Chemotherapy 53:410–417
Huisman C, Ferreira CG, Broker LE, Rodriguez JA, Smit EF, Postmus PE et al (2002) Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460. Clin Cancer Res 8:596–606
Huncharek M, Kupelnick B, Wheeler L (2003) Dietary cured meat and the risk of adult glioma: a meta-analysis of nine observational studies. J Environ Pathol Toxicol Oncol 22:129–137
Impens, F., Van Damme, P., Demol, H., Van Damme, J., Vandekerckhove, J., and Gevaert, K. 2008. Mechanistic insight into taxol-induced cell death. Oncogene 2008 (in press)
Janssen K, Pohlmann S, Janicke RU, Schulze-Osthoff K, Fischer U (2007) Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during taxol treatment. Blood 110:3662–3672
Karabatsou K, Bernstein M (2008) Cure following gene therapy for recurrent glioblastoma multiforme? Acta Neurochir (Wien) 150:611–612
Konduri SD, Srivenugopal KS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Foster DC, Kisiel W, Ali-Osman F, Kondraganti S, Lakka SS, Rao JS (2003) Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. Oncogene 22:4509–4516
Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF (2007) siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs. Clin Exp Pharmacol Physiol 34:450–456
Leung SY, Jackson J, Miyake H, Burt H, Gleave ME (2000) Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors. Prostate 44:156–163
Lewis R, Rempala G, Dell LD, Mundt KA (2003) Vinyl chloride and liver and brain cancer at a polymer production plant in Louisville, Kentucky. J Occup Environ Med 45:533–537
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157
Lü X, de la Peña L, Barker C, Camphausen K, Tofilon PJ (2006) Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes. Cancer Res 66:1052–1061
Manfredi JJ, Horwitz SB (1984) Taxol: an antimitotic agent with a new mechanism of action. Pharmacol Ther 25:83–125
Martinez R, Setien F, Voelter C, Casado S, Quesada MP, Schackert G, Esteller M (2007) CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis 28:1264–1268
Menéndez M, Rivas G, Díaz JF, Andreu JM (1998) Control of the structural stability of the tubulin dimer by one high affinity bound magnesium ion at nucleotide N-site. J. Biol. Chem. 273:167–176
Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL (2004) Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23:596–604
Nikanjam M, Gibbs AR, Hunt CA, Budinger TF, Forte TM (2007) Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme. J Control Release 124:163–171
Nimmanapalli R, Perkins CL, Orlando M, O’Bryan E, Nguyen D, Bhalla KN (2001) Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 61:759–763
Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, Komine C, Fukushima T (2006) Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas. Oncol Rep 16:957–963
Pineiro D, Martin ME, Guerra N, Salinas M, Gonzalez VM (2007) Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells. Exp Cell Res 313:369–379
Pulkkanen KJ, Yla-Herttuala S (2005) Gene therapy for malignant glioma: current clinical status. Mol Ther 12:585–598
Sasai K, Akagi T, Aoyanagi E, Tabu K, Kaneko S, Tanaka S (2007) O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies. Mol Cancer 6:36
Schiff PB, Horwitz SB (1980) Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77:1561–1565
Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665–667
Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2:494–503
Symmons MF, Martin SR, Bayley PM (1996) Dynamic properties of nucleated microtubules: GTP utilisation in the subcritical concentration regime. J Cell Sci 109:2755–2766
Takebayashi T, Varsier N, Kikuchi Y, Wake K, Taki M, Watanabe S, Akiba S, Yamaguchi N (2008) Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study. Br J Cancer 98:652–659
Thomson AB, Critchley HO, Wallace WH (2002) Fertility and progeny. Eur J Cancer 38:1634–1644
Trickler, W.J., Nagvekar, A.A., and Dash, A.K. 2008. A novel nanoparticle formulation for sustained paclitaxel delivery. AAPS PharmSci. Tech. 2008 (in press).
Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel. Pharm Res 24:1691–1701
Vivat-Hannah V, You D, Rizzo C, Daris JP, Lapointe P, Zusi FC, Marinier A, Lorenzi MV, Gottardis MM (2001) Synergistic cytotoxicity exhibited by combination treatment of selective retinoid ligands with taxol (Paclitaxel). Cancer Res 61:8703–8711
Wacheck V, Losert D, Günsberg P, Vornlocher HP, Hadwiger P, Geick A, Pehamberger H, Müller M, Jansen B (2003) Small interfering RNA targeting bcl-2 sensitizes malignant melanoma. Oligonucleotides 13:393–400
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327
Waring P, Kos FJ, Müllbacher A (1991) Apoptosis or programmed cell death. Med Res Rev 11:219–236
Wilson L, Bamburg JR, Mizel SB, Grisham LM, Creswell KM (1974) Interaction of drugs with microtubule proteins. Fed Proc 33:158–166
Xiao H, Verdier-Pinard P, Fernandez-Fuentes N, Burd B, Angeletti R, Fiser A, Horwitz SB, Orr GA (2006) Insights into the mechanism of microtubule stabilization by Taxol. Proc Natl Acad Sci USA 103:10166–10173
Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I (2005) Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177–187
Zheng T, Cantor KP, Zhang Y, Chiu BC, Lynch CF (2001) Risk of brain glioma not associated with cigarette smoking or use of other tobacco products in Iowa. Cancer Epidemiol Biomarkers Prev 10:413–414
Acknowledgments
This work was supported in part by the R01 grants (CA-91460 and NS-57811) from the National Institutes of Health (Bethesda, MD) to S.K.R.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag New York
About this chapter
Cite this chapter
George, J., Banik, N.L., Ray, S.K. (2010). Molecular Mechanisms of Taxol for Induction of Cell Death in Glioblastomas. In: Ray, S. (eds) Glioblastoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0410-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0410-2_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0409-6
Online ISBN: 978-1-4419-0410-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)